{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:11:00Z","timestamp":1783350660751,"version":"3.54.6"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uterus transplantation (UTx) is uniquely positioned at the transition from experimental to clinical reality for women with absolute uterine factor insufficiency. As the technique gains wider clinical adoption, there is a growing need for standardization in both protocols and diagnostics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>This review describes the current evaluation, monitoring, and emerging diagnostics in UTx across the main phases of care: (a) preoperative evaluation, which includes fertility evaluation and in vitro fertilization, surgical, psychosocial, and donor assessments, as well as donor\u2013recipient matching considerations; (b) perioperative management, which focuses on acute surgical care, initiation of immunosuppression, and early graft evaluation; (c) posttransplant and pregnancy monitoring, which encompasses ongoing immunosuppression evaluation, biopsy interpretation, management of acute rejection, and detection and management of pregnancy and maternal complications; and (d) long-term follow-up, which addresses the potential for repeat pregnancies and planned graft hysterectomy to facilitate immunosuppression withdrawal.<\/jats:p>\n                    <jats:p>The review further explores future directions for clinical diagnostics in UTx, drawing on broader solid organ transplantation experiences. This includes molecular and allele-level human leukocyte antigen matching for recipient\u2013donor compatibility, strategies for immunosuppression minimization, and the development of noninvasive rejection monitoring tools such as donor-derived cell-free DNA and novel blood and urine transcriptomics approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Standardization of protocols and diagnostics is essential as UTx transitions to routine clinical practice. Emerging molecular diagnostics and noninvasive monitoring tools hold promise for improving graft outcomes and patient care in this evolving field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaf143","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:31:45Z","timestamp":1761046305000},"page":"18-26","source":"Crossref","is-referenced-by-count":1,"title":["Uterus Transplantation\u2014Current Evaluation, Monitoring, and Emerging Diagnostics"],"prefix":"10.1093","volume":"72","author":[{"given":"Andrew","family":"Jacques","sequence":"first","affiliation":[{"name":"Department of Surgery, Baylor Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center , Dallas, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Testa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Baylor Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center , Dallas, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Mangiola","sequence":"additional","affiliation":[{"name":"New York University Langone Transplant Institute, NYU Langone Health , New York, NY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8572-3811","authenticated-orcid":false,"given":"Liza","family":"Johannesson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Baylor Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center , Dallas, TX ,","place":["United States"]},{"name":"Department of Obstetrics and Gynecology, Baylor University Medical Center , Dallas, TX ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2025123010595631200_hvaf143-B1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(14)61728-1","article-title":"Livebirth after uterus transplantation","volume":"385","author":"Br\u00e4nnstr\u00f6m","year":"2015","journal-title":"Lancet"},{"key":"2025123010595631200_hvaf143-B2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.2024.11679","article-title":"Uterus transplant in women with absolute uterine-factor infertility","volume":"332","author":"Testa","year":"2024","journal-title":"JAMA"},{"key":"2025123010595631200_hvaf143-B3","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1111\/ajt.15973","article-title":"Guidelines for standardized nomenclature and reporting in uterus transplantation: an opinion from the United States Uterus Transplant Consortium","volume":"20","author":"Johannesson","year":"2020","journal-title":"Am J Transplant"},{"key":"2025123010595631200_hvaf143-B4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/MOT.0000000000000931","article-title":"Uterus transplantation\u2014donor and recipient work-up","volume":"26","author":"Johannesson","year":"2021","journal-title":"Curr Opin Organ Transplant"},{"key":"2025123010595631200_hvaf143-B5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.fertnstert.2024.04.017","article-title":"In vitro fertilization practice in patients with absolute uterine factor undergoing uterus transplant in the United States","volume":"122","author":"Walter","year":"2024","journal-title":"Fertil Steril"},{"key":"2025123010595631200_hvaf143-B6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jamasurg.2022.2612","article-title":"The first 5 years of uterus transplant in the US: a report from the United States Uterus Transplant Consortium","volume":"157","author":"Johannesson","year":"2022","journal-title":"JAMA Surg"},{"key":"2025123010595631200_hvaf143-B7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/TP.0000000000004286","article-title":"Registry of the International Society of Uterus Transplantation: first report","volume":"107","author":"Br\u00e4nnstr\u00f6m","year":"2023","journal-title":"Transplantation"},{"key":"2025123010595631200_hvaf143-B8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.fertnstert.2024.04.019","article-title":"Classification and treatment of vaginal strictures at the donor-recipient anastomosis after uterus transplant","volume":"122","author":"Johannesson","year":"2024","journal-title":"Fertil Steril"},{"key":"2025123010595631200_hvaf143-B9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/TP.0000000000004437","article-title":"Immunosuppression in uterus transplantation: experience from the Dallas Uterus Transplant Study","volume":"107","author":"Wilson","year":"2023","journal-title":"Transplantation"},{"key":"2025123010595631200_hvaf143-B10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/TP.0000000000003633","article-title":"Clinicopathological analysis of uterine allografts including proposed scoring of ischemia reperfusion injury and T-cell-mediated rejection-Dallas UtErus Transplant Study: a pilot study","volume":"106","author":"Agarwal","year":"2022","journal-title":"Transplantation"},{"key":"2025123010595631200_hvaf143-B11","first-page":"1","article-title":"Trends and characteristics in gestational diabetes: United States, 2016\u20132020","volume":"71","author":"Gregory","year":"2022","journal-title":"Natl Vital Stat Rep"},{"key":"2025123010595631200_hvaf143-B12"},{"key":"2025123010595631200_hvaf143-B13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/AOG.0000000000005849","article-title":"Nationwide assessment of gestational age distribution at delivery for patients with placenta accreta spectrum disorder","volume":"145","author":"Matsuo","year":"2025","journal-title":"Obstet Gynecol"},{"key":"2025123010595631200_hvaf143-B14","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/1471-0528.17270","article-title":"Children after uterus transplantation: 2-year outcomes from the Dallas UtErus Transplant Study (DUETS)","volume":"129","author":"Schulz","year":"2022","journal-title":"BJOG"},{"key":"2025123010595631200_hvaf143-B15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0041-1727212","article-title":"Neonatal outcomes after uterus transplantation: Dallas Uterus Transplant Study","volume":"40","author":"York","year":"2023","journal-title":"Am J Perinatol"},{"key":"2025123010595631200_hvaf143-B16","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1097\/TXD.0000000000000664","article-title":"The risk of transplant failure with HLA mismatch in first adult kidney allografts 2: living donors, summary, guide","volume":"3","author":"Williams","year":"2017","journal-title":"Transplant Direct"},{"key":"2025123010595631200_hvaf143-B17","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1111\/j.1600-6143.2012.04226.x","article-title":"Association of HLA mismatch with death with a functioning graft after kidney transplantation: a collaborative transplant study report","volume":"12","author":"Opelz","year":"2012","journal-title":"Am J Transplant"},{"key":"2025123010595631200_hvaf143-B18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-5876-1-8","article-title":"Polymorphism in clinical immunology\u2014from HLA typing to immunogenetic profiling","volume":"1","author":"Jin","year":"2003","journal-title":"J Transl Med"},{"key":"2025123010595631200_hvaf143-B19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0115426588003006219","article-title":"Albumin synthesis and nutritional assessment","volume":"3","author":"Tayek","year":"1988","journal-title":"Nutr Clin Pract"},{"key":"2025123010595631200_hvaf143-B20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s42003-021-01989-3","article-title":"High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation","volume":"4","author":"Tran","year":"2021","journal-title":"Commun Biol"},{"key":"2025123010595631200_hvaf143-B21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.humimm.2021.11.005","article-title":"Role of HLA molecular mismatch in clinical practice","volume":"83","author":"Wiebe","year":"2022","journal-title":"Hum Immunol"},{"key":"2025123010595631200_hvaf143-B22","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/TP.0000000000001284","article-title":"Strategic use of epitope matching to improve outcomes","volume":"100","author":"Wiebe","year":"2016","journal-title":"Transplantation"},{"key":"2025123010595631200_hvaf143-B23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOT.0000000000000714","article-title":"Human leukocyte antigen molecular mismatch to risk stratify kidney transplant recipients","volume":"25","author":"Wiebe","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"2025123010595631200_hvaf143-B24","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1097\/TP.0000000000001667","article-title":"Are we ready for epitope-based HLA matching in clinical organ transplantation?","volume":"101","author":"Duquesnoy","year":"2017","journal-title":"Transplantation"},{"key":"2025123010595631200_hvaf143-B25","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/ajt.15177","article-title":"HLA-DR\/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity","volume":"19","author":"Wiebe","year":"2019","journal-title":"Am J Transplant"},{"key":"2025123010595631200_hvaf143-B26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MOT.0000000000001079","article-title":"HLA-DQ antibodies in alloimmunity, what makes them different?","volume":"28","author":"Meneghini","year":"2023","journal-title":"Curr Opin Organ Transplant"},{"key":"2025123010595631200_hvaf143-B27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","article-title":"Antigen-specific interaction between T and B cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"key":"2025123010595631200_hvaf143-B28","doi-asserted-by":"crossref","first-page":"1548934","DOI":"10.3389\/fimmu.2025.1548934","article-title":"Advancing risk stratification in kidney transplantation: integrating HLA-derived T-cell epitope and B-cell epitope matching algorithms for enhanced predictive accuracy of HLA compatibility","volume":"16","author":"Niemann","year":"2025","journal-title":"Front Immunol"},{"key":"2025123010595631200_hvaf143-B29","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.healun.2022.03.015","article-title":"Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II","volume":"41","author":"Mangiola","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"2025123010595631200_hvaf143-B30","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1681\/ASN.2017030287","article-title":"Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development","volume":"28","author":"Wiebe","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2025123010595631200_hvaf143-B31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/ajt.16290","article-title":"Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort","volume":"21","author":"Davis","year":"2021","journal-title":"Am J Transplant"},{"key":"2025123010595631200_hvaf143-B32","doi-asserted-by":"crossref","first-page":"1110292","DOI":"10.3389\/fimmu.2023.1110292","article-title":"Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II","volume":"14","author":"Ellison","year":"2023","journal-title":"Front Immunol"},{"key":"2025123010595631200_hvaf143-B33","doi-asserted-by":"crossref","first-page":"1442018","DOI":"10.3389\/fgene.2024.1442018","article-title":"Improving long-term kidney allograft survival by rethinking HLA compatibility: from molecular matching to non-HLA genes","volume":"15","author":"Mattoo","year":"2024","journal-title":"Front Genet"},{"key":"2025123010595631200_hvaf143-B34","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ajt.2024.11.030","article-title":"Balancing equity and human leukocyte antigen matching in deceased-donor kidney allocation with eplet mismatch","volume":"25","author":"Mankowski","year":"2025","journal-title":"Am J Transplant"},{"key":"2025123010595631200_hvaf143-B35","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41591-024-03087-3","article-title":"Cell-free DNA for the detection of kidney allograft rejection","volume":"30","author":"Aubert","year":"2024","journal-title":"Nat Med"},{"key":"2025123010595631200_hvaf143-B36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000004339","article-title":"Diagnostic potential of minimally invasive biomarkers: a biopsy-centered viewpoint from the Banff Minimally Invasive Diagnostics Working Group","volume":"107","author":"Huang","year":"2023","journal-title":"Transplantation"},{"key":"2025123010595631200_hvaf143-B37","doi-asserted-by":"crossref","first-page":"e2393","DOI":"10.1002\/rmv.2393","article-title":"Torque teno virus load as marker of rejection and infection in solid organ transplantation\u2014a systematic review and meta-analysis","volume":"33","author":"van Rijn","year":"2023","journal-title":"Rev Med Virol"},{"key":"2025123010595631200_hvaf143-B38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/v16010017","article-title":"Torque Teno Virus (TTV)-a potential marker of immunocompetence in solid organ recipients","volume":"16","author":"Kuczaj","year":"2023","journal-title":"Viruses"},{"key":"2025123010595631200_hvaf143-B39","doi-asserted-by":"crossref","first-page":"e29554","DOI":"10.1002\/jmv.29554","article-title":"The kinetics of Torque Teno virus plasma load following calcineurin inhibitor dose change in kidney transplant recipients","volume":"96","author":"Regele","year":"2024","journal-title":"J Med Virol"},{"key":"2025123010595631200_hvaf143-B40","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.ekir.2024.04.054","article-title":"Relevance of the Banff human organ transplant consensus gene panel for detecting antibody and T-cell-mediated rejection of kidney allografts","volume":"9","author":"Giarraputo","year":"2024","journal-title":"Kidney Int Rep"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/1\/18\/66163551\/hvaf143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/72\/1\/18\/66163551\/hvaf143.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:00:11Z","timestamp":1767110411000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/72\/1\/18\/8407364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2025,12,30]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaf143","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,30]]}}}